These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36195305)
1. Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy. Ma Y; Chen Z; He Q; Guo ZN; Yang Y; Liu F; Li F; Luo Q; Chang J Pharmacol Res; 2022 Nov; 185():106482. PubMed ID: 36195305 [TBL] [Abstract][Full Text] [Related]
2. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia. Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322 [TBL] [Abstract][Full Text] [Related]
3. Development of a carotid artery thrombolysis stroke model in mice. Maclean JAA; Tomkins AJ; Sturgeon SA; Hofma BR; Alwis I; Samson AL; Schoenwaelder SM; Jackson SP Blood Adv; 2022 Sep; 6(18):5449-5462. PubMed ID: 35767737 [TBL] [Abstract][Full Text] [Related]
7. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats. Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator. Huang Y; Han Z; Shen T; Zheng Y; Yang Z; Fan J; Wang R; Yan F; Tao Z; Luo Y; Liu P CNS Neurosci Ther; 2024 Jul; 30(7):e14825. PubMed ID: 38954749 [TBL] [Abstract][Full Text] [Related]
9. Lipidomics Analysis Reveals a Protective Effect of Myriocin on Cerebral Ischemia/Reperfusion Model Rats. Wang T; Zhang J; Yang M; Guo J; Li D; Li Y J Mol Neurosci; 2022 Sep; 72(9):1846-1858. PubMed ID: 35776315 [TBL] [Abstract][Full Text] [Related]
10. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke. Huang Y; Gu S; Han Z; Yang Z; Zhong L; Li L; Wang R; Yan F; Luo Y; Borlongan C; Lu J J Am Heart Assoc; 2023 Sep; 12(17):e029817. PubMed ID: 37655472 [TBL] [Abstract][Full Text] [Related]
12. Reduced Severity of Tissue Injury Within the Infarct May Partially Mediate the Benefit of Reperfusion in Ischemic Stroke. Ng FC; Churilov L; Yassi N; Kleinig TJ; Thijs V; Wu TY; Shah DG; Dewey HM; Sharma G; Desmond PM; Yan B; Parsons MW; Donnan GA; Davis SM; Mitchell PJ; Leigh R; Campbell BCV; Stroke; 2022 Jun; 53(6):1915-1923. PubMed ID: 35135319 [TBL] [Abstract][Full Text] [Related]
13. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595 [TBL] [Abstract][Full Text] [Related]
15. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke. Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413 [TBL] [Abstract][Full Text] [Related]
16. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318 [TBL] [Abstract][Full Text] [Related]
17. Cerebral edema in acute stroke: Effect of thrombolytic treatment. Frisullo G; Bellavia S; Scala I; Rizzo PA; Broccolini A; Brunetti V; Pepe M; Pilato F; Morosetti R; Marca GD; Calabresi P J Neurol Sci; 2022 May; 436():120206. PubMed ID: 35259555 [TBL] [Abstract][Full Text] [Related]
18. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats. Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619 [TBL] [Abstract][Full Text] [Related]
19. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420 [TBL] [Abstract][Full Text] [Related]
20. Relation between reperfusion and hemorrhagic transformation in acute ischemic stroke. Horsch AD; Dankbaar JW; van der Graaf Y; Niesten JM; van Seeters T; van der Schaaf IC; Kappelle LJ; Velthuis BK; Neuroradiology; 2015 Dec; 57(12):1219-25. PubMed ID: 26337766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]